title: Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
authors.affiliation: Clinical Center for Research Excellence, Charles R. Drew University, 1731 E. 120th St., Los Angeles, CA 90059, USA.
authors.forename: Piya
authors.initials: P
authors.lastname: Ballani
authors.forename: Michael T
authors.initials: MT
authors.lastname: Tran
authors.forename: Maria D
authors.initials: MD
authors.lastname: Navar
authors.forename: Mayer B
authors.initials: MB
authors.lastname: Davidson
mesh_terms: D000328:Adult; D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin